Drugs & TargetsFree Cellectar Biosciences Inc. receives second-phase of NCI SBIR award August 05, 2016Vol.42 No.31
Drugs & TargetsFree Advanced Accelerator Applications and NCI form clinical trial agreement August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA and CMS to undergo parallel review of FoundationOne genomic assay August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA Grants Breakthrough Therapy Designation to LEE011 in Metastatic Breast Cancer August 05, 2016Vol.42 No.31
Drugs & Targets Mylan and Biocon submit marketing application to EMA for biosimilar Pegfilgrastim July 29, 2016Vol.42 No.30
Drugs & Targets CHMP Issues Positive Opinion for Onivyde Combination in Pancreatic Adenocarcinoma July 29, 2016Vol.42 No.30
Drugs & Targets GlaxoSmithKline and University of Leicester to form collaboration July 22, 2016Vol.42 No.29
Drugs & Targets CHMP issues positive opinion for Kisplyx in renal cell carcinoma July 22, 2016Vol.42 No.29
